Exciting News! FDA Clears Aruna Bio's IND for AB126 – A Major Milestone in Advancing Medical Innovation!! We are thrilled to announce a groundbreaking achievement for Aruna Bio as the FDA grants clearance for the Investigational New Drug (IND) application for AB126! This milestone represents a testament to our unwavering commitment to advancing medical innovation and bringing transformative solutions to patients in need. AB126, a first-in-class neural exosome, holds great promise in treating both acute and chronic CNS indications. Our dedicated team has worked tirelessly to reach this stage, and we are excited about the potential impact that AB126 can have on acute ischemic stroke and chronic neurodegenerative conditions. Thank you to everyone who has been part of this journey. Stay tuned for more updates as we continue to innovate! Learn More: https://lnkd.in/eMWcA7Dg #healthcareadvancements #biotechinnovation #stroke #stroketreatment #cns
关于我们
Aruna Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. We are leveraging our proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing our exosomes with small molecules, RNA, oligonucleotides and antibodies.
- 网站
-
https://www.arunabio.com
Aruna Bio, Inc.的外部链接
- 所属行业
- 研究服务
- 规模
- 11-50 人
- 总部
- Athens，GA
- 类型
- 教育机构
- 创立
- 2003
- 领域
- Stem cells、Neural stem cells、Drug toxicity assay、high throughput screening services、stroke、exosome、CNS、neurodegenerative disorders和drug development
地点
-
主要
获取路线
425 River Road
US，GA，Athens，30602
Aruna Bio, Inc.员工
-
Skip Irving
Chairman, The Michael J. Fox Foundation for Parkinson's Research
-
Tracey Worthington Stice
Chief Operating Officer
-
Steven Stice
D. W. Brooks Distinguished Professor; GRA Scholar; Director of Regenerative Bioscience Center at University of Georgia
-
Stephen From
Biotech CEO | Fundraising & M&A Expert | CNS and Ophthalmology Drug Development Leader | Exosome-Based Therapy
动态
-
Attending BIO 2024? Click below to send Aruna Bio?a meeting request in the BIO partnering system!?#BIO2024 https://lnkd.in/dA5REsef
-
Our CEO Stephen From will be attending BIO International 2024 in San Diego, CA. The CNS space is a very exciting and active therapy area, and we would love to connect with those who share our passion for exosomes and exosome-based therapeutics. Any parties interested in connecting should reach out via the BIO Partnering platform, or send an email to [email protected]. #BIO2024